E2814 tau antibody (DIAD)
A Phase 2 study of E2814, an investigational anti-tau antibody, in people with genetic early Alzheimer’s disease.
Overview
Target-engagement and safety study in a DIAD population. Not an approved treatment and not a DIY protocol.
Similar pages
not linked directly; found by shared links- TechnologyTau-directed therapeutics
Shares E2814, Alzheimer’s disease and the tag dementia-atlas.
- TrialCLARITY AD
Shares Eisai, Alzheimer’s disease and the tag dementia-atlas.
- TargetTau
Shares E2814, Alzheimer’s disease and the tag dementia-atlas.
- PersonAlois Alzheimer
Shares Alzheimer’s disease and the tag dementia-atlas.
- TreatmentBrexpiprazole
Shares Alzheimer’s disease and the tag dementia-atlas.
- CollectionClinicalTrials.gov
Shares Alzheimer’s disease and the tag dementia-atlas.
- TreatmentMemantine
Shares Alzheimer’s disease and the tag dementia-atlas.
- InstitutionNational Institute on Aging
Shares Alzheimer’s disease and the tag dementia-atlas.